X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1909) 1909
Book Review (371) 371
Publication (164) 164
Book Chapter (6) 6
Conference Proceeding (4) 4
Paper (2) 2
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1481) 1481
helicobacter pylori (1425) 1425
humans (1353) 1353
eradication (1289) 1289
helicobacter infections - drug therapy (1072) 1072
gastroenterology & hepatology (1006) 1006
male (816) 816
infection (813) 813
female (805) 805
helicobacter pylori - drug effects (767) 767
clarithromycin (723) 723
middle aged (678) 678
adult (623) 623
anti-bacterial agents - therapeutic use (612) 612
drug therapy, combination (582) 582
triple therapy (564) 564
amoxicillin (553) 553
treatment outcome (484) 484
aged (469) 469
helicobacter infections - microbiology (461) 461
metronidazole (451) 451
microbiology (449) 449
antibiotic-resistance (404) 404
resistance (339) 339
omeprazole (334) 334
clarithromycin - therapeutic use (332) 332
helicobacter infections (329) 329
helicobacter pylori - isolation & purification (327) 327
pharmacology & pharmacy (316) 316
eradication therapy (312) 312
amoxicillin - therapeutic use (302) 302
anti-bacterial agents - pharmacology (290) 290
anti-bacterial agents - administration & dosage (279) 279
drug resistance, bacterial (274) 274
metaanalysis (265) 265
antibiotics (262) 262
management (262) 262
microbial sensitivity tests (259) 259
therapy (253) 253
prevalence (243) 243
helicobacter infections - diagnosis (237) 237
adolescent (234) 234
efficacy (233) 233
health aspects (220) 220
levofloxacin (219) 219
metronidazole - therapeutic use (214) 214
amoxicillin - administration & dosage (213) 213
anti-ulcer agents - therapeutic use (213) 213
prospective studies (212) 212
duodenal-ulcer (208) 208
proton pump inhibitors - therapeutic use (205) 205
proton pump inhibitors (198) 198
quadruple therapy (190) 190
sequential therapy (188) 188
antimicrobial resistance (187) 187
clarithromycin - administration & dosage (187) 187
clarithromycin - pharmacology (185) 185
care and treatment (179) 179
proton pump inhibitor (172) 172
drug administration schedule (171) 171
antibiotic resistance (170) 170
medicine, general & internal (170) 170
breath tests (165) 165
infections (165) 165
aged, 80 and over (163) 163
clarithromycin resistance (163) 163
helicobacter infections - epidemiology (159) 159
treatment failure (158) 158
drug resistance in microorganisms (156) 156
lansoprazole (156) 156
young adult (156) 156
anti-bacterial agents - adverse effects (154) 154
helicobacter pylori - genetics (150) 150
helicobacter infections - complications (148) 148
omeprazole - therapeutic use (148) 148
analysis (141) 141
abridged index medicus (136) 136
drug resistance (135) 135
metronidazole - pharmacology (133) 133
metronidazole - administration & dosage (132) 132
metronidazole resistance (130) 130
bismuth (129) 129
children (127) 127
gastritis (125) 125
biopsy (124) 124
infectious diseases (124) 124
child (122) 122
drug resistance, microbial (122) 122
consensus report (121) 121
gastroenterology (119) 119
strains (119) 119
ulcers (119) 119
antiulcer drugs (116) 116
susceptibility (116) 116
gastric-cancer (114) 114
anti-ulcer agents - administration & dosage (113) 113
rabeprazole (113) 113
urea (112) 112
rescue therapy (111) 111
diagnosis (109) 109
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1825) 1825
Korean (28) 28
Spanish (23) 23
French (17) 17
German (10) 10
Russian (7) 7
Japanese (3) 3
Polish (3) 3
Turkish (3) 3
Croatian (2) 2
Hungarian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 8/2016, Volume 61, Issue 8, pp. 2373 - 2380
Helicobacter pylori antibiotic resistance leads to frequent treatment failure. However, the current US prevalence of H. pylori clarithromycin resistance and... 
Biochemistry, general | Clarithromycin | 23S rRNA | Medicine & Public Health | Helicobacter pylori | Hepatology | Gastroenterology | Antibiotic resistance | Oncology | Treatment failure | Transplant Surgery | UNITED-STATES | RISK-FACTORS | MANAGEMENT | SUSCEPTIBILITY | ANTIMICROBIAL RESISTANCE | NATIVE PERSONS | CHILDREN | ALASKA SENTINEL SURVEILLANCE | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | United States - epidemiology | Prevalence | Humans | Middle Aged | Helicobacter pylori - genetics | Male | Bismuth - therapeutic use | Gastric Mucosa | Antacids - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | RNA, Ribosomal, 23S - genetics | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Treatment Failure | Aged, 80 and over | Gastritis - microbiology | Adult | Female | Retrospective Studies | Drug Resistance, Bacterial - genetics | Drug Therapy, Combination | Gastritis - drug therapy | Helicobacter Infections - epidemiology | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Gastritis - epidemiology | Adolescent | Amoxicillin - therapeutic use | Aged | Helicobacter pylori - physiology | Cohort Studies | Helicobacter Infections - microbiology | Drug resistance in microorganisms | RNA | Gastrointestinal diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 3/2012, Volume 47, Issue 3, pp. 276 - 283
In recent years in Japan, the rate of clarithromycin (CAM) resistance in Helicobacter pylori has risen to around 30%, and the eradication rate with triple... 
Eradication of Helicobacter pylori | Large-scale observational study | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Oncology | Internal Medicine | Rabeprazole | Surgical Oncology | Triple therapy | Clarithromycin resistance | Eradication of Helicobacter pylori - Clarithromycin resistance | LANSOPRAZOLE | MANAGEMENT | DUODENAL-ULCER | OMEPRAZOLE | SMOKING | DOSE CLARITHROMYCIN | PROTON PUMP INHIBITOR | DOUBLE-BLIND | RESISTANCE | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Multivariate Analysis | Prospective Studies | Humans | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Dose-Response Relationship, Drug | Young Adult | Anti-Bacterial Agents - therapeutic use | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Clarithromycin - adverse effects | Japan | Anti-Ulcer Agents - adverse effects | Clarithromycin - therapeutic use | Anti-Ulcer Agents - administration & dosage | Adolescent | Amoxicillin - therapeutic use | Sex Factors | Amoxicillin - adverse effects | Aged | Helicobacter pylori - isolation & purification | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Helicobacter Infections - microbiology | Allergy | Endoscopic surgery | Medical colleges | Clarithromycin | Diarrhea | Antibacterial agents | Patient compliance | Allergic reaction | Antiulcer drugs | Helicobacter pylori | Analysis | Gastrointestinal diseases | Amoxicillin | Penicillin | Proton pump inhibitors | Respiratory tract diseases | Endoscopy | Universities and colleges | Drugs | Protons | Hypersensitivity | Ulcers | Sex | Multivariate analysis | Index Medicus
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 03/2017, Volume 64, Issue 3, pp. e56 - e60
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 2684836 - 12
Journal Article
Journal of Global Antimicrobial Resistance, ISSN 2213-7165, 06/2017, Volume 9, pp. 43 - 46
Clarithromycin resistance (CLR-R) is the main reason for failure of infection treatment, which is frequently empirically prescribed due to the erroneous belief... 
Clarithromycin | 23S rRNA | Mutation | Helicobacter pylori | Susceptibility-guided treatment | Gastroduodenal biopsy | ANTIMICROBIAL SUSCEPTIBILITY | INFECTIOUS DISEASES | 23S RIBOSOMAL-RNA | PHARMACOLOGY & PHARMACY | ERADICATION | INFECTION | Drug resistance in microorganisms | Helicobacter infections | Drug therapy | Patient outcomes | Testing | Observations
Journal Article